Manuka Honey Reduces NETosis on an Electrospun Template Within a Therapeutic Window
Benjamin A Minden-Birkenmaier1, Richard A Smith2, Marko Z Radic3
1Department of Biomedical Engineering, University of Memphis, 330 Engineering Technology Building, Memphis, TN 38152, USA.
Polymers
|July 2, 2020
Summary
Manuka honey in tissue engineering templates can reduce neutrophil extracellular trap formation (NETosis) at low concentrations (0.1%, 1%), potentially aiding chronic wound healing. Higher concentrations (10%) exacerbated this response.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Wound Healing Research
Background:
- Manuka honey is a known topical wound treatment with antibacterial and anti-inflammatory properties.
- Its potential as a tissue template additive in tissue engineering is being explored.
- The effect of Manuka honey on neutrophil extracellular trap formation (NETosis) within tissue engineering templates remains uninvestigated.
Purpose of the Study:
- To examine the impact of Manuka honey incorporation into electrospun tissue engineering templates on NETosis.
- To determine the optimal concentration of Manuka honey for modulating NETosis in a wound healing context.
Main Methods:
- Manuka honey was incorporated into electrospun templates with varying fiber diameters (large and small).
- Template pore sizes and honey release kinetics were analyzed.
- Human neutrophils seeded on templates were assessed for NETosis via fluorescence imaging and myeloperoxidase (MPO) analysis.
- Matrix metalloproteinase-9 (MMP-9) release was also quantified.
Main Results:
- Low concentrations of Manuka honey (0.1% and 1%) significantly reduced NETosis on the template surface at 3 and 6 hours.
- A high concentration (10%) of Manuka honey increased NETosis.
- Low Manuka honey concentrations also decreased MMP-9 release from neutrophils.
Conclusions:
- A therapeutic window exists for Manuka honey incorporation into tissue engineering templates to reduce NETosis.
- These findings suggest Manuka honey could be beneficial in managing chronic inflammation and fibrosis in wound environments.
- Further in vivo studies are warranted to validate these results in a physiological setting.


